Arthneeti
BC

Bodal Chemicals Ltd

Q2 FY26Chemicals & Petrochemicals

Bodal Chemicals Q2 FY26 earnings call: Revenue & Margins

Q2 FY26 investor presentation: what the company reported on revenue, margins and projects.

Price₹195
Market cap₹2.4K Cr
P/E35.1
Updated24 Sept 2026
Read4 min read

Based on Bodal Chemicals Ltd's Q2 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

Q2 FY26 consolidated revenue from operations: Rs 4,804.5 mn, up 11.2% YoY from Rs 4,321.2 mn (Page 10). Quarterly EBITDA (Q2 FY26): Rs.

From Bodal Chemicals Ltd's Q2 FY26 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Q2 FY26 consolidated revenue from operations: Rs 4,804.5 mn, up 11.2% YoY from Rs 4,321.2 mn (Page 10).
  • Q2 FY26 standalone revenue from operations: Rs 4,719.6 mn, up 10.7% YoY from Rs 4,262.1 mn (Page 11).
  • Q2 FY26 consolidated EBITDA at Rs 429.1 mn, up 13.7% YoY; standalone EBITDA Rs 432.1 mn, up 15.9% YoY (Pages 10-11).
  • Segment revenues for Q2 FY26 (consolidated):
  • Basic Chemicals: Rs 331 mn, +42% YoY
  • Dyestuff: Rs 1,322 mn, +7% YoY
  • Dye Intermediates: Rs 1,834 mn, +7% YoY
  • Chlor Alkali: Volume 841 MT, Revenue Rs 7968 mn (H1 data)

2 more points management made on revenue & sales performance

Profitability & Margins

See what Bodal Chemicals Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • The presentation mentions a "new greenfield expansion" as part of the company's way forward strategy (Page 28).
  • Capacity ramp-up is highlighted as a key focus area to strengthen market leadership (Page 28).
  • Capital Work-In-Progress stood at Rs. 613.2 Mn as of Sep-25 and Rs. 607.7 Mn as of Mar-25, indicating ongoing capital expenditure (Page 12).
  • No specific amounts, detailed project descriptions, or precise timelines for capex or new plants/projects are explicitly stated in the presentation.

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

5x potential
1Shiv Texchem
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Bodal Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided investor presentation for Bodal Chemicals Ltd. does not explicitly mention any details regarding order book, order inflow, or pending orders. The presentation focuses primarily on financial highlights, key ratios, product overview, geographical footprint, subsidiaries' performance, and management information. Key financial metrics like revenue, EBITDA, PAT, and balance sheet data are included, but there is no specific data or commentary on order book status, order inflow, or backlog of pending orders in the visible pages of the presentation.

Bodal Chemicals Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹588 Cr, net profit ₹32 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Bodal Chemicals Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Chemcon Speciality Chemicals Ltd (Q2 FY26)

    Q2 FY26 revenue from operations: ₹53.7 crore, up 2% YoY (vs ₹52.6 crore in Q2 FY25) [Page 9, 6] . Key concall takeaways from Chemcon Speciality Chemicals Ltd's…

  • Valiant Organics Ltd (Q2 FY26)

    Q2-FY26 consolidated revenue from operations: INR 1,573 million, down 1.8% year-on-year (Page 12). Key concall takeaways from Valiant Organics Ltd's Q2 FY26…

  • Indian Phosphate Ltd (Q2 FY26)

    H1 FY 25-26 revenue increased by ~15% to ₹451 crores versus ₹385 crores in H1 FY 24-25. Key concall takeaways from Indian Phosphate's Q2 FY26 earnings call…

  • Alkyl Amines Chemicals Ltd (Q2 FY26)

    120 crores. Key concall takeaways from Alkyl Amines Chemicals Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.

Compare:vs Solar Industries India Ltdvs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Bodal Chemicals Ltd Q2 FY26 results?

Q2 FY26 consolidated revenue from operations: Rs 4,804.5 mn, up 11.2% YoY from Rs 4,321.2 mn (Page 10). Quarterly EBITDA (Q2 FY26): Rs.

What is Bodal Chemicals Ltd share price analysis?

Bodal Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 35.1 with a market cap of ₹2,408 Cr. Investors should review the full earnings analysis for detailed insights.

Is Bodal Chemicals Ltd planning capital expenditure?

The presentation mentions a "new greenfield expansion" as part of the company's way forward strategy (Page 28). - Capacity ramp-up is highlighted as a key focus area to strengthen market leadership (Page 28). - Capital Work-In-Progress stood at Rs.

Keep Bodal Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.